Literature DB >> 19395025

BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.

Agnieszka Bojarska-Junak1, Iwona Hus, Sylwia Chocholska, Ewa Wasik-Szczepanek, Małgorzata Sieklucka, Anna Dmoszyńska, Jacek Roliński.   

Abstract

B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) are involved in normal B cell survival and differentiation. We analyzed BAFF and APRIL plasma levels in patients with B-cell chronic lymphocytic leukemia (B-CLL). We also tested intracellular BAFF and APRIL expression in B-CLL and evaluated their prognostic relevance. The percentage of leukemic B cells with intracellular APRIL or BAFF expression correlated significantly with adverse prognostic factors such as ZAP-70 and CD38. Moreover, we found a close relationship between LPL protein expression or LPL/ADAM29 MFI ratio and proportion of B-CLL cells with intracellular BAFF or APRIL expression. Furthermore, patients with a low percentage of leukemic cells with intracellular BAFF or APRIL expression had a significantly longer overall survival than those with a high proportion of APRIL or BAFF positive leukemic cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19395025     DOI: 10.1016/j.leukres.2009.03.030

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  19 in total

1.  Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies.

Authors:  Stephen A Mihalcik; Renee C Tschumper; Diane F Jelinek
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

2.  Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemia.

Authors:  Barbara L Andersen; Neha Godiwala Goyal; David M Weiss; Travis D Westbrook; Kami J Maddocks; John C Byrd; Amy J Johnson
Journal:  Cancer       Date:  2018-05-14       Impact factor: 6.860

3.  Dequalinium induces apoptosis in peripheral blood mononuclear cells isolated from human chronic lymphocytic leukemia.

Authors:  Lucia Pajuelo; Eva Calviño; Jose Carlos Diez; Maria Del Carmen Boyano-Adánez; Juana Gil; Pilar Sancho
Journal:  Invest New Drugs       Date:  2010-06-05       Impact factor: 3.850

4.  Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.

Authors:  Ru Wang; Yichao Guo; Hongzhi Ma; Lin Feng; Qi Wang; Xiaohong Chen; Meng Lian; Haizhou Wang; Jugao Fang
Journal:  Tumour Biol       Date:  2015-09-23

5.  Prognostic Significance of Serum BAFF, APRIL, TACI and BCMA Levels in Chronic Lymphocytic Leukemia.

Authors:  İlay Berke Menteşe; Zeynep Arzu Yegin; Sanem Gökçen; Zübeyde Nur Özkurt; Münci Yağcı
Journal:  Indian J Hematol Blood Transfus       Date:  2018-10-10       Impact factor: 0.900

6.  Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.

Authors:  Amit K Mittal; Nagendra K Chaturvedi; Karan J Rai; Christine E Gilling-Cutucache; Tara M Nordgren; Margaret Moragues; Runqing Lu; Rene Opavsky; Greg R Bociek; Dennis D Weisenburger; Javeed Iqbal; Shantaram S Joshi
Journal:  Mol Med       Date:  2014-07-15       Impact factor: 6.354

7.  Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.

Authors:  Charalampos Pontikoglou; Maria-Christina Kastrinaki; Mirjam Klaus; Christina Kalpadakis; Pavlos Katonis; Kalliopi Alpantaki; Gerassimos A Pangalis; Helen A Papadaki
Journal:  Stem Cells Dev       Date:  2013-02-01       Impact factor: 3.272

Review 8.  B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.

Authors:  G Galletti; F Caligaris-Cappio; M T S Bertilaccio
Journal:  Leukemia       Date:  2016-09-28       Impact factor: 11.528

9.  Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.

Authors:  Clare Sun; Xin Tian; Yuh Shan Lee; Sreenivasulu Gunti; Andrew Lipsky; Sarah E M Herman; Dalia Salem; Maryalice Stetler-Stevenson; Constance Yuan; Lela Kardava; Susan Moir; Irina Maric; Janet Valdez; Susan Soto; Gerald E Marti; Mohammed Z Farooqui; Abner L Notkins; Adrian Wiestner; Georg Aue
Journal:  Blood       Date:  2015-09-03       Impact factor: 22.113

10.  Characterization of Lamprey BAFF-like Gene: Evolutionary Implications.

Authors:  Sabyasachi Das; Yoichi Sutoh; Masayuki Hirano; Qifeng Han; Jianxu Li; Max D Cooper; Brantley R Herrin
Journal:  J Immunol       Date:  2016-08-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.